Form D · Biotechnology
Synthetica Bio, Inc.
Anaheim, CA · CIK 0001981956
Offering snapshot reported Aug 29, 2023 · SEC filing
- Reported sold
- $4.25M Offering amount: $4.25M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 30, 2023 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$4,000,000 → $4,250,000
- Reported investors15 → 16
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 29, 2023 | Amendment | $4,250,000 | $250,000vs Aug 2, 2023 | 16 | SEC filing |
| Aug 2, 2023 | Amendment | $4,000,000 | $1,500,000vs Jul 5, 2023 | 15 | SEC filing |
| Jul 5, 2023 | Amendment | $2,500,000 | $1,175,000vs Jun 16, 2023 | 13 | SEC filing |
| Jun 16, 2023 | Initial | $1,325,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-484503
Source: Form D, filed Aug 29, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Simon Arkell | Director, Executive |
| Alexander Dickinson | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1950 W Corporate Way, #12489
Anaheim, CA, 92801
Anaheim, CA, 92801